NCT03323346 2025-07-20
DISC
The Institute of Molecular and Translational Medicine, Czech Republic
Phase 2 Recruiting
Clinical Trials
4 trialsNCT01777919 2025-05-25
GLIODIS
Olympion Medical Center
Phase 2 Not yet recruiting
NCT05709171 2023-11-22
Dual 64Cu-DOTATATE and 18F-FDG PET/CT Imaging of Patients With Neuroendocrine Neoplasms
Rigshospitalet, Denmark
Phase 2 Unknown
NCT04265274 2023-10-06
Vinorelbine, Cisplatin, Disulfiram and Copper in CTC_EMT Positive Refractory Metastatic Breast Cancer.
National Cancer Institute, Slovakia
Phase 2 Withdrawn